Booth D, Davis JA, McEwan P, Solomon SD, et al. The cost-effectiveness of dapagliflozin in heart failure with preserved or mildly reduced ejection fraction: A European health-economic analysis of the DELIVER trial. Eur J Heart Fail 2023 Jun 21. doi: 10.1002/ejhf.2940.
PMID: 37344985